None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with schizophrenia spectrum and other psychotic disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria, whose acute psychotic symptoms had remitted and who were in a stable condition (Clinical Global Impression score of 4 or below), and who were able to provide informed consent and adequately cooperate with and complete the study assessments.
Exclusion criteria
Exclusion criteria: Individuals with a serious concurrent medical condition resulting in poor general health status; pregnant or breastfeeding women; those with an intellectual disability with an IQ of 70 or below; those with severely impaired reality testing that would preclude informed consent or study participation; and those currently receiving inpatient treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adherence Rating Scale (ARS);Subjective Well-being under Neuroleptic Treatment Scale (SWN);Udvalg for Kliniske Undersøgelser (UKU) Side Effect Rating Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Positive and Negative Syndrome Scale (PANSS);Social and Occupational Functioning Assessment Scale (SOFAS);Korean Version of the Scale to Assess Unawareness of Mental Disorder (SUMD-K) | — |
Countries
Korea, Republic of
Contacts
Jeonbuk National University Hospital